Abbott Laboratories logo
Abbott Laboratories (ABT)
Compare

Abbott Laboratories (ABT) EV/Sales Ratio: 4.07x

Is Abbott Laboratories’s EV/Sales ratio high or low?

Abbott Laboratories's EV/Sales ratio of 4.07x is 18% below its 5-year average of 4.98x, near the low end of its 5-year range (3.74x–6.20x).

As of Thursday, June 11, 2026. 17.56% below its 12-month average of 4.94x.

ABT EV/Sales Ratio Chart

ABT EV/Sales Ratio
4.07x-29.09% 1Y
Zoom

ABT Average EV/Sales Ratio Chart

ABT Current vs Average EV/Sales Ratio Chart

ABT EV/Sales Ratio Metrics

EV/SALES RATIO

4.07x

EV/SALES RATIO AVG TTM

4.94x

EV/SALES RATIO AVG 3Y

5.00x

EV/SALES RATIO AVG 5Y

4.98x

EV/SALES RATIO AVG 10Y

4.93x

EV/SALES RATIO AVG 15Y

4.09x

EV/SALES RATIO AVG 20Y

3.52x

CURRENT VS TTM AVG

-17.56%

CURRENT VS 3Y AVG

-18.65%

CURRENT VS 5Y AVG

-18.29%

CURRENT VS 10Y AVG

-17.37%

CURRENT VS 15Y AVG

-0.47%

CURRENT VS 20Y AVG

+15.75%

ABT Competitors' EV/Sales Ratio

NAMEMARKET CAPEV/SALES RATIOTTM3Y5Y
Abbott Laboratories (ABT)$155.75B4.07x4.94x5.00x4.98x
Gilead Sciences, Inc. (GILD)$156.35B5.61x6.02x4.98x4.64x
Pfizer Inc. (PFE)$149.61B3.37x3.30x3.43x3.63x
Intuitive Surgical, Inc. (ISRG)$144.79B13.82x18.43x19.52x18.69x
Thermo Fisher Scientific Inc. (TMO)$176.21B4.80x5.13x5.38x5.61x
CVS Health Corporation (CVS)$126.70B0.48x0.44x0.43x0.51x
Danaher Corporation (DHR)$126.39B5.79x6.63x7.16x7.00x
Amgen Inc. (AMGN)$188.37B6.15x6.19x6.53x6.38x
Bristol-Myers Squibb Company (BMY)$116.13B3.12x2.99x3.12x3.47x
Vertex Pharmaceuticals Incorporated (VRTX)$110.59B8.91x9.43x10.00x9.07x

Understanding EV/Sales

Enterprise Value (EV) = Market Cap + Total Debt - Cash

Sales = Total Revenue (TTM)

EV/Sales is commonly used because:

  • It works for unprofitable companies where P/E doesn't apply
  • Revenue is harder to manipulate than earnings
  • It supports comparisons across companies at different profitability stages
  • It is frequently used for software and other revenue-growth-focused companies

Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.

Abbott Laboratories EV/Sales Ratio Formula & Definition

EV/Sales = Enterprise Value / Revenue (TTM)

Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Abbott Laboratories EV/Sales Ratio FAQ

What is the EV/Sales ratio for Abbott Laboratories (ABT)?
The EV/Sales ratio for ABT stock is 4.07x.
Is Abbott Laboratories's EV/Sales ratio high or low?
Abbott Laboratories's EV/Sales ratio of 4.07x is 18% below its 5-year average of 4.98x, near the low end of its 5-year range (3.74x–6.20x).
What is the TTM average EV/Sales ratio for Abbott Laboratories (ABT)?
The TTM average EV/Sales ratio for ABT stock is 4.94x.
What is the 3Y average EV/Sales ratio for Abbott Laboratories (ABT)?
The 3Y average EV/Sales ratio for ABT stock is 5.00x.
What is the 5Y average EV/Sales ratio for Abbott Laboratories (ABT)?
The 5Y average EV/Sales ratio for ABT stock is 4.98x.
What is the 10Y average EV/Sales ratio for Abbott Laboratories (ABT)?
The 10Y average EV/Sales ratio for ABT stock is 4.93x.
What is the 15Y average EV/Sales ratio for Abbott Laboratories (ABT)?
The 15Y average EV/Sales ratio for ABT stock is 4.09x.
What is the 20Y average EV/Sales ratio for Abbott Laboratories (ABT)?
The 20Y average EV/Sales ratio for ABT stock is 3.52x.

Abbott Laboratories EV/Sales Ratio History

DATEEV/SALES RATIO
2026-06-114.07x
2026-06-104.06x
2026-06-094.14x
2026-06-084.11x
2026-06-054.13x
2026-06-044.12x
2026-06-033.97x
2026-06-023.97x
2026-06-014.00x
2026-05-293.92x
2026-05-283.94x
2026-05-273.92x
2026-05-263.96x
2026-05-223.99x
2026-05-214.00x
2026-05-204.02x
2026-05-194.04x
2026-05-184.01x
2026-05-153.87x
2026-05-143.89x
2026-05-133.85x
2026-05-123.87x
2026-05-113.80x
2026-05-083.87x
2026-05-073.97x
2026-05-063.94x
2026-05-053.98x
2026-05-043.99x
2026-05-014.07x
2026-04-304.12x
2026-04-294.14x
2026-04-283.85x
2026-04-273.80x
2026-04-243.74x
2026-04-233.79x
2026-04-223.76x
2026-04-213.80x
2026-04-203.93x
2026-04-173.96x
2026-04-163.91x
2026-04-154.15x
2026-04-144.13x
2026-04-134.12x
2026-04-104.10x
2026-04-094.20x
2026-04-084.23x
2026-04-074.16x
2026-04-064.18x
2026-04-024.20x
2026-04-014.18x
2026-03-314.19x
2026-03-304.16x
2026-03-274.25x
2026-03-264.27x
2026-03-254.28x
2026-03-244.25x
2026-03-234.28x
2026-03-204.30x
2026-03-194.37x
2026-03-184.42x
2026-03-174.51x
2026-03-164.48x
2026-03-134.41x
2026-03-124.41x
2026-03-114.49x
2026-03-104.50x
2026-03-094.59x
2026-03-064.47x
2026-03-054.52x
2026-03-044.61x
2026-03-034.63x
2026-03-024.65x
2026-02-274.73x
2026-02-264.73x
2026-02-254.67x
2026-02-244.66x
2026-02-234.69x
2026-02-204.57x
2026-02-194.60x
2026-02-184.64x
2026-02-174.60x
2026-02-134.62x
2026-02-124.57x
2026-02-114.66x
2026-02-104.60x
2026-02-094.55x
2026-02-064.55x
2026-02-054.48x
2026-02-044.44x
2026-02-034.47x
2026-02-024.49x
2026-01-304.48x
2026-01-294.36x
2026-01-284.35x
2026-01-274.44x
2026-01-264.46x
2026-01-234.41x
2026-01-224.46x
2026-01-214.94x
2026-01-204.96x
2026-01-164.98x
2026-01-155.05x
2026-01-145.11x
2026-01-135.08x
2026-01-125.10x
2026-01-095.15x
2026-01-085.16x
2026-01-075.19x
2026-01-065.22x
2026-01-055.17x
2026-01-025.08x
2025-12-315.12x
2025-12-305.14x
2025-12-295.09x
2025-12-265.10x
2025-12-245.10x
2025-12-235.09x
2025-12-225.12x
2025-12-195.13x
2025-12-185.12x
2025-12-175.18x
2025-12-165.18x
2025-12-155.25x
2025-12-125.13x
2025-12-115.04x
2025-12-105.01x
2025-12-094.96x
2025-12-084.99x
2025-12-055.11x
2025-12-045.13x
2025-12-035.12x
2025-12-025.16x
2025-12-015.23x
2025-11-285.27x
2025-11-265.25x
2025-11-255.23x
2025-11-245.20x
2025-11-215.23x
2025-11-205.07x
2025-11-195.16x
2025-11-185.31x
2025-11-175.31x
2025-11-145.33x
2025-11-135.28x
2025-11-125.26x
2025-11-115.19x
2025-11-105.15x
2025-11-075.16x
2025-11-065.11x
2025-11-055.09x
2025-11-045.14x
2025-11-035.06x
2025-10-315.06x
2025-10-305.10x
2025-10-295.09x
2025-10-285.29x
2025-10-275.32x
2025-10-245.30x
2025-10-235.28x
2025-10-225.35x
2025-10-215.33x
2025-10-205.41x
2025-10-175.37x
2025-10-165.33x
2025-10-155.41x
2025-10-145.56x
2025-10-135.49x
2025-10-105.54x
2025-10-095.57x
2025-10-085.60x
2025-10-075.55x
2025-10-065.58x
2025-10-035.62x
2025-10-025.55x
2025-10-015.57x
2025-09-305.59x
2025-09-295.56x
2025-09-265.57x
2025-09-255.57x
2025-09-245.59x
2025-09-235.67x
2025-09-225.70x
2025-09-195.68x
2025-09-185.62x
2025-09-175.60x
2025-09-165.54x
2025-09-155.48x
2025-09-125.58x
2025-09-115.54x
2025-09-105.40x
2025-09-095.51x
2025-09-085.52x
2025-09-055.55x
2025-09-045.54x
2025-09-035.52x
2025-09-025.49x
2025-08-295.54x
2025-08-285.49x
2025-08-275.49x
2025-08-265.50x
2025-08-255.51x
2025-08-225.54x
2025-08-215.51x
2025-08-205.53x
2025-08-195.48x
2025-08-185.44x
2025-08-155.50x
2025-08-145.40x
2025-08-135.41x
2025-08-125.47x
2025-08-115.49x
2025-08-085.60x
2025-08-075.51x
2025-08-065.47x
2025-08-055.46x
2025-08-045.43x
2025-08-015.32x
2025-07-315.28x
2025-07-305.37x
2025-07-295.44x
2025-07-285.37x
2025-07-255.38x
2025-07-245.34x
2025-07-235.35x
2025-07-225.35x
2025-07-215.29x
2025-07-185.26x
2025-07-175.13x
2025-07-165.59x
2025-07-155.58x
2025-07-145.61x
2025-07-115.61x
2025-07-105.67x
2025-07-095.66x
2025-07-085.66x
2025-07-075.68x
2025-07-035.71x
2025-07-025.69x
2025-07-015.78x
2025-06-305.77x
2025-06-275.70x
2025-06-265.67x
2025-06-255.83x
2025-06-245.86x
2025-06-235.66x
2025-06-205.65x
2025-06-185.62x
2025-06-175.62x
2025-06-165.69x
2025-06-135.75x
2025-06-125.79x
2025-06-115.74x
2025-06-105.69x
2025-06-095.66x
2025-06-065.67x
2025-06-055.69x
2025-06-045.64x
2025-06-035.68x
2025-06-025.67x
2025-05-305.67x

Showing the most recent 260 of 5,032 data points. The chart above shows the full history.

About Abbott Laboratories

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

Abbott Park, IL
114,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Robert Ford